Research programme: cancer vaccines - GeovaxAlternative Names: MVA-VLP cancer vaccine - GeoVax Labs
Latest Information Update: 21 Nov 2016
At a glance
- Originator GeoVax Labs
- Developer GeoVax Labs; University of Pittsburgh
- Class Cancer vaccines; DNA vaccines; Virus-like particle vaccines
- Mechanism of Action Immunostimulants; Mucin 1 modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Cancer